Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;94(1):76-80.
doi: 10.1111/j.1349-7006.2003.tb01355.x.

Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus

Ja-Mun Chong  1 , Kazuya Sakuma, Makoto Sudo, Tetsuo Ushiku, Hiroshi Uozaki, Junji Shibahara, Hideo Nagai, Nobuaki Funata, Hirokazu Taniguchi, Hiroyuki Aburatani, Masashi Fukayama
Affiliations

Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus

Ja-Mun Chong et al. Cancer Sci. 2003 Jan.

Abstract

DNA hypermethylation may play a primary role in the genesis of Epstein-Barr virus (EBV)-associated gastric carcinoma (GC) (EBVaGC). Methylation-specific PCR targeting CpG-islands demonstrated markedly increased methylation of specific genes, such as p14, p15 and p16 genes, in EBVaGC in vivo. A high frequency of methylation was observed in an EBVaGC strain of severe combined immunodeficiency mice, and the expression of methylated genes in the strain was apparently lower than the expression of the unmethylated genes in EBV-negative GC strains. Although over-expression of DNA methyltransferases (DNMTs) is known to be associated with some human cancers, real-time PCR demonstrated that DNMTs expression was suppressed in EBVaGC. The DNA methylation of specific genes, independently of DNMTs expression, may be important in the development of EBVaGC.

PubMed Disclaimer

References

    1. Fukayama M, Chong J‐M, Uozaki H. Epstein‐Barr virus and human cancer. Current topics in microbiology and immunology. In: Takada, K , editor. Pathology and molecular pathology of Epstein‐Barr virus‐associated gastric carcinoma. Berlin : Springer; 2001. p. 91–102. - PubMed
    1. Fukayama M, Chong J‐M, Kaizaki Y. Epstein‐Barr virus and gastric carcinoma. Gastric Cancer 1998; 1: 104–14. - PubMed
    1. Fukayama M, Hayashi Y, Iwasaki Y, Chong J‐M, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K. Epstein‐Barr virus‐associated gastric carcinoma and Epstein‐Barr virus infection of the stomach. Lab Invest 1994; 71: 73–81. - PubMed
    1. Chong J‐M, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama, M. Interleukin 1β expression in human gastric carcinoma with Epstein‐Barr virus infection. J Virol 2002; 76: 6825–31. - PMC - PubMed
    1. Chong J‐M, Fukayama M, Hayashi Y, Funata N, Takizawa T, Koike M, Muraoka M, Kikuchi‐Yanoshita R, Miyaki M, Mizuno S. Expression of CD44 variants in gastric carcinoma with or without Epstein‐Barr virus. Int J Cancer 1997; 74: 450–4. - PubMed

Publication types

MeSH terms